Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Head and Neck Cancer

  Free Subscription

Articles published in Int J Cancer

Retrieve available abstracts of 65 articles:
HTML format

Single Articles

    December 2022
  1. JIN Z, Pei S, Ouyang L, Zhang L, et al
    Thy-Wise: An interpretable machine learning model for the evaluation of thyroid nodules.
    Int J Cancer. 2022;151:2229-2243.
    PubMed     Abstract available

    November 2022
  2. HAO Y, Karaoz U, Yang L, Yachimski PS, et al
    Progressive dysbiosis of human orodigestive microbiota along the sequence of gastroesophageal reflux, Barrett's esophagus and esophageal adenocarcinoma.
    Int J Cancer. 2022;151:1703-1716.
    PubMed     Abstract available

  3. YANG H, Wang XK, Wang JB, Zhao FH, et al
    Combined risk factors and risk of upper gastrointestinal cancer mortality in the Linxian general population.
    Int J Cancer. 2022;151:1462-1473.
    PubMed     Abstract available

    October 2022
  4. HERMUS M, van der Wilk BJ, Chang RTH, Collee G, et al
    Patient preferences for active surveillance versus standard surgery after neoadjuvant chemoradiotherapy in esophageal cancer treatment: the NOSANO-study.
    Int J Cancer. 2022 Oct 17. doi: 10.1002/ijc.34327.
    PubMed     Abstract available

  5. WANG Q, Xie H, Li Y, Theodoropoulos N, et al
    Racial and ethnic disparities in nasopharyngeal cancer with an emphasis among Asian Americans.
    Int J Cancer. 2022;151:1291-1303.
    PubMed     Abstract available

  6. SOROUSH A, Malekzadeh R, Roshandel G, Khoshnia M, et al
    Sex and smoking differences in the association between gastroesophageal reflux and risk of esophageal squamous cell carcinoma in a high-incidence area: Golestan Cohort Study.
    Int J Cancer. 2022 Oct 10. doi: 10.1002/ijc.34313.
    PubMed     Abstract available

  7. MA Y, Li W, Chen S, Lin S, et al
    Characteristics and response to next-generation sequencing-guided therapy in locally advanced or metastatic esophageal cancer.
    Int J Cancer. 2022 Oct 10. doi: 10.1002/ijc.34315.
    PubMed     Abstract available

    September 2022
  8. ZHU H, Ma X, Ye T, Wang H, et al
    Esophageal cancer in China: practice and research in the new era.
    Int J Cancer. 2022 Sep 24. doi: 10.1002/ijc.34301.
    PubMed     Abstract available

  9. POELL JB, Wils LJ, Brink A, Dietrich R, et al
    Oral cancer prediction by noninvasive genetic screening.
    Int J Cancer. 2022 Sep 7. doi: 10.1002/ijc.34277.
    PubMed     Abstract available

    August 2022
  10. GHOLAP D, Dikshit R, Chaturvedi P, Chaturvedi AK, et al
    Exclusive use of different types of tobacco products, exposure to second hand tobacco smoke and risk of subtypes of head and neck cancer among Indian males.
    Int J Cancer. 2022 Aug 27. doi: 10.1002/ijc.34258.
    PubMed     Abstract available

  11. LIU Y, Zheng Z, Li M, Zhang Y, et al
    Comparison of concurrent chemoradiotherapy with radiotherapy alone for locally advanced esophageal squamous cell cancer in elderly patients: A randomized, multicenter, phase II clinical trial.
    Int J Cancer. 2022;151:607-615.
    PubMed     Abstract available

  12. TIAN Y, Tang C, Shi G, Wang G, et al
    Novel fluorescent GLUT1 inhibitor for precision detection and fluorescence image-guided surgery in oral squamous cell carcinoma.
    Int J Cancer. 2022;151:450-462.
    PubMed     Abstract available

  13. AN L, Zheng R, Zeng H, Zhang S, et al
    The survival of esophageal cancer by subtype in China with comparison to the United States.
    Int J Cancer. 2022 Aug 1. doi: 10.1002/ijc.34232.
    PubMed     Abstract available

    July 2022
  14. NOMBURG J, Bullman S, Nasrollahzadeh D, Collisson EA, et al
    An international report on bacterial communities in esophageal squamous cell carcinoma.
    Int J Cancer. 2022 Jul 15. doi: 10.1002/ijc.34212.
    PubMed     Abstract available

    June 2022
  15. WANG S, Zheng R, Arnold M, Abnet C, et al
    Global and national trends in the age-specific sex ratio of esophageal cancer and gastric cancer by subtype.
    Int J Cancer. 2022 Jun 9. doi: 10.1002/ijc.34158.
    PubMed     Abstract available

    May 2022
  16. IM PK, Yang L, Kartsonaki C, Chen Y, et al
    Alcohol metabolism genes and risks of site-specific cancers in Chinese adults: An 11-year prospective study.
    Int J Cancer. 2022;150:1627-1639.
    PubMed     Abstract available

    April 2022
  17. COLLATUZZO G, Etemadi A, Sotoudeh M, Nikmanesh A, et al
    Meat consumption and risk of esophageal and gastric cancer in the Golestan Cohort Study, Iran.
    Int J Cancer. 2022 Apr 30. doi: 10.1002/ijc.34056.
    PubMed     Abstract available

  18. LAAKSONEN MA, MacInnis RJ, Canfell K, Shaw JE, et al
    Thyroid cancers potentially preventable by reducing overweight and obesity in Australia: A pooled cohort study.
    Int J Cancer. 2022;150:1281-1290.
    PubMed     Abstract available

  19. LIU H, Li G, Sturgis EM, Shete S, et al
    Genetic variants in CYP2B6 and HSD17B12 associated with the risk of squamous cell carcinoma of the head and neck.
    Int J Cancer. 2022 Apr 11. doi: 10.1002/ijc.34023.
    PubMed     Abstract available

  20. GARSET-ZAMANI M, Carlander AF, Jakobsen KK, Friborg J, et al
    Impact of specific high-risk human papillomavirus genotypes on survival in oropharyngeal cancer.
    Int J Cancer. 2022;150:1174-1183.
    PubMed     Abstract available

    March 2022
  21. LONG Z, Wang W, Liu W, Wang F, et al
    Trend of nasopharyngeal carcinoma mortality and years of life lost in China and Its Provinces from 2005 to 2020.
    Int J Cancer. 2022 Mar 14. doi: 10.1002/ijc.33998.
    PubMed     Abstract available

  22. RETTIG EM, Faden DL, Sandhu S, Wong K, et al
    Detection of Circulating Tumor Human Papillomavirus DNA Before Diagnosis of HPV-Positive Head and Neck Cancer.
    Int J Cancer. 2022 Mar 9. doi: 10.1002/ijc.33996.
    PubMed     Abstract available

    February 2022
  23. ANTONSSON A, de Souza MMA, Panizza BJ, Whiteman DC, et al
    Sexual debut and association with oral HPV infection, persistence and oropharyngeal cancer - an analysis of two Australian cohorts.
    Int J Cancer. 2022 Feb 28. doi: 10.1002/ijc.33986.
    PubMed     Abstract available

  24. LIU J, Li J, Lin W, Shao D, et al
    Neoadjuvant camrelizumab plus chemotherapy for resectable, locally advanced esophageal squamous cell carcinoma (NIC-ESCC2019): a multicenter, phase 2 study.
    Int J Cancer. 2022 Feb 21. doi: 10.1002/ijc.33976.
    PubMed     Abstract available

  25. WURSTHORN A, Schwager C, Kurth I, Peitzsch C, et al
    High-Complexity cellular barcoding and clonal tracing reveals stochastic and deterministic parameters of radiation resistance.
    Int J Cancer. 2022;150:663-677.
    PubMed     Abstract available

  26. PATEL KK, Chakravarti P, Chaturvedi P, Dikshit R, et al
    The fifth round of the National Family Health Survey of India 2019 to 2021 reported low screening uptake alarming to strengthen the implementation of early detection services of the cervix, breast and oral cancer.
    Int J Cancer. 2022 Feb 6. doi: 10.1002/ijc.33958.

  27. LIU X, Liu P, Chernock RD, Lang Kuhs KA, et al
    Impact of human papillomavirus on the tumor microenvironment in oropharyngeal squamous cell carcinoma.
    Int J Cancer. 2022;150:521-531.
    PubMed     Abstract available

  28. DE VEGT F, Gommers JJJ, Groenewoud H, Siersema PD, et al
    Trends and projections in the incidence of oesophageal cancer in the Netherlands: An age-period-cohort analysis from 1989 to 2041.
    Int J Cancer. 2022;150:420-430.
    PubMed     Abstract available

  29. GHANTOUS Y, Omar M, Broner EC, Agrawal N, et al
    A robust and interpretable gene signature for predicting the lymph node status of primary T1/T2 oral cavity squamous cell carcinoma.
    Int J Cancer. 2022;150:450-460.
    PubMed     Abstract available

    January 2022
  30. VAN DER WATT PJ, Okpara MO, Wishart A, Parker MI, et al
    Nuclear transport proteins are secreted by cancer cells and identified as potential novel cancer biomarkers.
    Int J Cancer. 2022;150:347-361.
    PubMed     Abstract available

  31. GAO P, Cai N, Yang X, Yuan Z, et al
    Association of Helicobacter pylori and gastric atrophy with adenocarcinoma of the esophagogastric junction in Taixing, China.
    Int J Cancer. 2022;150:243-252.
    PubMed     Abstract available

  32. KRENS SD, van Boxtel W, Uijen MJM, Jansman FGA, et al
    Exposure-toxicity relationship of cabozantinib in patients with renal cell cancer and salivary gland cancer.
    Int J Cancer. 2022;150:308-316.
    PubMed     Abstract available

    December 2021
  33. DENEUVE S, Perol O, Dantony E, Guizard AV, et al
    Diverging incidence trends of oral tongue cancer compared to other head and neck cancers in young adults in France.
    Int J Cancer. 2021 Dec 10. doi: 10.1002/ijc.33896.
    PubMed     Abstract available

    November 2021
  34. LASSEN P, Huang SH, Su J, Waldron J, et al
    Treatment outcomes and survival following definitive (chemo) radiotherapy in HPV-positive oropharynx cancer: Large-scale comparison of DAHANCA vs PMH cohorts.
    Int J Cancer. 2021 Nov 18. doi: 10.1002/ijc.33876.
    PubMed     Abstract available

    October 2021
  35. TAWK B, Wirkner U, Schwager C, Rein K, et al
    Tumor DNA-Methylome derived Epigenetic Fingerprint Identifies HPV-negative Head and Neck Patients at Risk for Locoregional Recurrence after Postoperative Radiochemotherapy.
    Int J Cancer. 2021 Oct 14. doi: 10.1002/ijc.33842.
    PubMed     Abstract available

    September 2021
  36. DE LA COUR CD, von Buchwald C, Dehlendorff C, Garset-Zamani M, et al
    Low-dose aspirin use and mortality risk in patients with head and neck cancer - a nationwide cohort study of 10,770 patients.
    Int J Cancer. 2021 Sep 18. doi: 10.1002/ijc.33814.
    PubMed     Abstract available

  37. CABASAG CJ, Arnold M, Pineros M, Morgan E, et al
    Population-based cancer staging for oesophageal, gastric, and pancreatic cancer 2012-2014: International Cancer Benchmarking Partnership SurvMark-2.
    Int J Cancer. 2021;149:1239-1246.
    PubMed     Abstract available

  38. TANAKA H, Suzuki M, Takemoto N, Fukusumi T, et al
    Performance of Oral HPV DNA, Oral HPV mRNA, and Circulating Tumor HPV DNA in the Detection of HPV-Related Oropharyngeal Cancer and Cancer of Unknown Primary.
    Int J Cancer. 2021 Sep 6. doi: 10.1002/ijc.33798.
    PubMed     Abstract available

  39. NABHAN F, Dedhia PH, Ringel MD
    Thyroid cancer, recent advances in diagnosis and therapy.
    Int J Cancer. 2021;149:984-992.
    PubMed     Abstract available

    July 2021
  40. NAUTA IH, Heideman DAM, Brink A, van der Steen B, et al
    The unveiled reality of human papillomavirus as risk factor for oral cavity squamous cell carcinoma.
    Int J Cancer. 2021;149:420-430.
    PubMed     Abstract available

    June 2021
  41. BUDUKH A, Dikshit R, Chaturvedi P
    Outcome of the randomized control screening trials on Oral, Cervix and Breast Cancer from India and way forward in COVID-19 pandemic situation.
    Int J Cancer. 2021 Jun 21. doi: 10.1002/ijc.33712.

  42. TRUONG T, Lesueur F, Sugier PE, Guibon J, et al
    Multiethnic genome-wide association study of differentiated thyroid cancer in the EPITHYR consortium.
    Int J Cancer. 2021;148:2935-2946.
    PubMed     Abstract available

    May 2021
  43. HOFHEINZ RD, Hegewisch-Becker S, Kunzmann V, Thuss-Patience P, et al
    Trastuzumab in combination with 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) as perioperative treatment for patients with HER2-positive locally advanced esophagogastric adenocarcinoma: A phase II trial of the AIO Gastric Cancer Study G
    Int J Cancer. 2021 May 21. doi: 10.1002/ijc.33696.
    PubMed     Abstract available

  44. NARH CT, Dzamalala CP, Mmbaga BT, Menya D, et al
    Geophagia and risk of squamous cell esophageal cancer in the African esophageal cancer corridor - Findings from the ESCCAPE multi-country case-control studies.
    Int J Cancer. 2021 May 18. doi: 10.1002/ijc.33688.
    PubMed     Abstract available

    April 2021
  45. BUSSMANN L, Hoffer K, von Bargen CM, Droste C, et al
    Analyzing tyrosine kinase activity in head and neck cancer by functional kinomics: Identification of hyperactivated Src-family kinases as prognostic markers and potential targets.
    Int J Cancer. 2021 Apr 22. doi: 10.1002/ijc.33606.
    PubMed     Abstract available

  46. SHI Z, Wei J, Na R, Resurreccion WK, et al
    Cystic fibrosis F508del carriers and cancer risk: Results from the UK Biobank.
    Int J Cancer. 2021;148:1658-1664.
    PubMed     Abstract available

  47. LING Z, Cheng B, Tao X
    Epithelial-to-mesenchymal transition in oral squamous cell carcinoma: Challenges and opportunities.
    Int J Cancer. 2021;148:1548-1561.
    PubMed     Abstract available

    March 2021
  48. MIDDLETON DRS, Mmbaga BT, O'Donovan M, Abedi-Ardekani B, et al
    Minimally invasive esophageal sponge cytology sampling is feasible in a Tanzanian community setting.
    Int J Cancer. 2021;148:1208-1218.
    PubMed     Abstract available

  49. IMAMURA Y, Toihata T, Haraguchi I, Ogata Y, et al
    Immunogenic characteristics of microsatellite instability-low esophagogastric junction adenocarcinoma based on clinicopathological, molecular, immunological and survival analyses.
    Int J Cancer. 2021;148:1260-1275.
    PubMed     Abstract available

  50. LIU Y, Lai F, Long J, Peng S, et al
    Screening and the epidemic of thyroid cancer in China: An analysis of national representative inpatient and commercial insurance databases.
    Int J Cancer. 2021;148:1106-1114.
    PubMed     Abstract available

    February 2021
  51. PARAD MT, Fararouei M, Mirahmadizadeh AR, Afrashteh S, et al
    Thyroid cancer and its associated factors: a population based case-control study.
    Int J Cancer. 2021 Feb 26. doi: 10.1002/ijc.33537.
    PubMed     Abstract available

  52. XIE SH, Ness-Jensen E, Langseth H, Gislefoss RE, et al
    Prediagnostic circulating levels of sex hormones and survival in esophageal adenocarcinoma.
    Int J Cancer. 2021;148:905-913.
    PubMed     Abstract available

    January 2021
  53. TAKADA K, Aizawa Y, Sano D, Okuda R, et al
    Establishment of PDX-derived salivary adenoid cystic carcinoma cell lines using organoid culture method.
    Int J Cancer. 2021;148:193-202.
    PubMed     Abstract available

    December 2020
  54. CHOI J, Jia G, Wen W, Long J, et al
    Evaluating polygenic risk scores in assessing risk of nine solid and hematologic cancers in European descendants.
    Int J Cancer. 2020;147:3416-3423.
    PubMed     Abstract available

  55. ANTONSSON A, de Souza M, Wood ZC, Carroll A, et al
    Natural history of oral HPV infection - longitudinal analyses in prospective cohorts from Australia.
    Int J Cancer. 2020 Dec 15. doi: 10.1002/ijc.33442.
    PubMed     Abstract available

    November 2020
  56. SONG L, Zhang S, Yu S, Ma F, et al
    Cellular heterogeneity landscape in laryngeal squamous cell carcinoma.
    Int J Cancer. 2020;147:2879-2890.
    PubMed     Abstract available

  57. CAPPAGLI V, Caldarella A, Manneschi G, Piaggi P, et al
    Nonthyroidal second primary malignancies in differentiated thyroid cancer patients: Is the incidence increased comparing to the general population and could it be a radioiodine therapy consequence?
    Int J Cancer. 2020;147:2838-2846.
    PubMed     Abstract available

  58. GARCIA RODRIGUEZ LA, Soriano-Gabarro M, Vora P, Cea Soriano L, et al
    Low-dose aspirin and risk of gastric and oesophageal cancer: A population-based study in the United Kingdom using The Health Improvement Network.
    Int J Cancer. 2020;147:2394-2404.
    PubMed     Abstract available

  59. JUWEID ME, Tulchinsky M, Mismar A, Momani M, et al
    Contemporary considerations in adjuvant radioiodine treatment of adults with differentiated thyroid cancer.
    Int J Cancer. 2020;147:2345-2354.
    PubMed     Abstract available

    October 2020
  60. BASILI T, Dopeso H, Kim SH, Ferrando L, et al
    Oncogenic properties and signaling basis of the PAX8-GLIS3 fusion gene.
    Int J Cancer. 2020;147:2253-2264.
    PubMed     Abstract available

  61. YUAN S, Kar S, Vithayathil M, Carter P, et al
    Causal associations of thyroid function and dysfunction with overall, breast and thyroid cancer: A two-sample Mendelian randomization study.
    Int J Cancer. 2020;147:1895-1903.
    PubMed     Abstract available

    September 2020
  62. SIRRI E, Kieschke J, Vohmann C, Katalinic A, et al
    Survival of malignant mesothelioma and other rare thoracic cancers in Germany and the United States: A population-based study.
    Int J Cancer. 2020;147:1548-1558.
    PubMed     Abstract available

    August 2020
  63. BOSETTI C, Carioli G, Santucci C, Bertuccio P, et al
    Global trends in oral and pharyngeal cancer incidence and mortality.
    Int J Cancer. 2020;147:1040-1049.
    PubMed     Abstract available

    May 2020
  64. MESSERSCHMIDT C, Obermayer B, Klinghammer K, Ochsenreither S, et al
    Distinct immune evasion in APOBEC-enriched, HPV-negative HNSCC.
    Int J Cancer. 2020 May 29. doi: 10.1002/ijc.33123.
    PubMed     Abstract available

    November 2019
  65. VEYER D, Wack M, Mandavit M, Garrigou S, et al
    HPV circulating tumoral DNA quantification by droplet-based digital PCR: a promising predictive and prognostic biomarker for HPV-associated oropharyngeal cancers.
    Int J Cancer. 2019 Nov 22. doi: 10.1002/ijc.32804.

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.